Launched in 2002, Creadev is an evergreen investment company backed by the Mulliez family.We look to invest and support companies able to scale-up and become worldwide best players in their sectors. Our sectors of interest are Healthcare, Food and Sustainable Consumption.We have invested over €2bn at various stages of development, from venture capital to growth equity and buyout. Annual investment capacity up to €250m.

Life science strategy consulting (Dec. 2020 to May 2022): early stage asset strategy, R&D portfolio review, due diligence, evidence generation plan, digital therapeutics, clinical opsReal-world evidence (June 2022 to Aug. 2023): development of partnerships with European cancer centers and delivery of large-scale real-world evidence studies

Design & operational delivery of health innovations at group level (incl. telehealth, digital therapeutics, data analytics, appointment booking)

Core member of BCG's healthcare practice (incl. providers, payers, pharma, medtech): • Oncology strategy for a major group of hospitals • Launch strategy of an innovative drug in the immunology space • Due diligences of medtech companies • Global growth strategy for a health re-insurer (leading to creation of new BU) • Partnership negociation between global health institutions • Paper about the requirements of value-based health care in emerging markets • Diagnosis of medicine management value chain for a ministry of health • Support to a multi-country procurement agency in its negotiations with pharma companies

Associate from January 2012 to June 2013.Senior associate from July 2013 to December 2013.Consultant from January 2014 to June 2016